<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4710">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03045614</url>
  </required_header>
  <id_info>
    <org_study_id>AZ 238/16</org_study_id>
    <nct_id>NCT03045614</nct_id>
  </id_info>
  <brief_title>Prevalence of Kidney Disease, Hemodynamic Predictors and Long-Term Renal Outcome in Pulmonary Hypertension</brief_title>
  <official_title>Prevalence of Kidney Disease, Hemodynamic Predictors and Long-Term Renal Outcome in Pulmonary Hypertension - A Single Centre, Retrospective Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the prevalence of kidney disease, hemodynamic predictors and long-term renal
      outcome in patients with pulmonary hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to determine the prevalence of kidney disease, hemodynamic predictors during
      right heart catheterization and long-term renal outcome in patients with pulmonary
      hypertension.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Classification of hemodynamic parameters measured at time-point of right heart catheterization according to kidney function stages 1-5.</measure>
    <time_frame>At baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality of patients with pulmonary hypertension during follow-up period based on kidney function stages 1-5 measured at time-point of right heart catheterization.</measure>
    <time_frame>3 years follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated GFR decline in each class of pulmonary hypertension during follow-up period</measure>
    <time_frame>3 years follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Predictive value of central venous pressure and b-type natriuretic peptide at time of right heart catheterization for development of chronic kidney disease.</measure>
    <time_frame>3 years follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of diuretics in patients with pulmonary hypertension at time of right heart catheterization.</measure>
    <time_frame>At baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1700</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Collection of only residual material (blood, urine) for Deutsche Zentrum f√ºr Lungenforschung
      Biobank.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with diagnosed PH undergoing right heart catheterization between 1999 and
        2013
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Older than 18 years

        Exclusion Criteria:

          -  Patients with estimated GFR &lt; 15ml/min or with chronic dialysis treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Werner Seeger, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Clinic Giessen and Marburg - Campus Giessen, Department of Internal Medicine II, Division of Pulmonology, Nephrology and Critical Care Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faeq Husain-Syed, MD</last_name>
    <phone>+49 641 985 42378</phone>
    <email>faeq.husain-syed@innere.med.uni-giessen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Henning Gall, MD</last_name>
    <phone>+49 641 985 42351</phone>
    <email>henning.gall@innere.med.uni-giessen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Clinic Giessen and Marburg - Campus Giessen</name>
      <address>
        <city>Giessen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faeq Husain-Syed, MD</last_name>
      <phone>+49 641 985 42378</phone>
      <email>faeq.husain-syed@innere.med.uni-giessen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV Jr, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May;9(5):855-63. doi: 10.2215/CJN.10191013. Epub 2014 Feb 27.</citation>
    <PMID>24578332</PMID>
  </results_reference>
  <results_reference>
    <citation>Husain-Syed F, Slutsky AS, Ronco C. Lung-Kidney Cross-Talk in the Critically Ill Patient. Am J Respir Crit Care Med. 2016 Aug 15;194(4):402-14. doi: 10.1164/rccm.201602-0420CP.</citation>
    <PMID>27337068</PMID>
  </results_reference>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 6, 2017</lastchanged_date>
  <firstreceived_date>February 4, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Giessen</investigator_affiliation>
    <investigator_full_name>Faeq Husain</investigator_full_name>
    <investigator_title>Senior Physician Nephrology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
